Geode Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,571,081 shares of RARE stock, worth $70.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,571,081

Previous 1,505,458 4.36%

Holding current value

$70.3 Million

Previous $61.9 Million 41.05%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$40.21 - $59.36 $2.64 Million - $3.9 Million	65,623 Added 4.36%	1,571,081 $87.3 Million
Q2 2024 Aug 09, 2024	BUY	$37.42 - $51.61 $6.2 Million - $8.55 Million	165,632 Added 12.36%	1,505,458 $61.9 Million
Q1 2024 May 13, 2024	BUY	$43.02 - $53.69 $2.42 Million - $3.02 Million	56,204 Added 4.38%	1,339,826 $62.6 Million
Q4 2023 Feb 13, 2024	BUY	$31.73 - $49.19 $6.36 Million - $9.85 Million	200,335 Added 18.49%	1,283,622 $61.4 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $791,776 - $1.06 Million	22,674 Added 2.14%	1,083,287 $38.6 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $1.72 Million - $2.4 Million	45,973 Added 4.53%	1,060,613 $48.9 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $1.17 Million - $1.54 Million	31,610 Added 3.22%	1,014,640 $40.7 Million
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $1.96 Million - $2.69 Million	58,153 Added 6.29%	983,030 $45.5 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $645,913 - $1.07 Million	16,164 Added 1.78%	924,877 $38.3 Million
Q2 2022 Aug 12, 2022	BUY	$45.8 - $85.4 $266,235 - $496,430	5,813 Added 0.64%	908,713 $54.2 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $1.61 Million - $2.19 Million	25,944 Added 2.96%	902,900 $65.6 Million
Q4 2021 Feb 11, 2022	BUY	$73.71 - $87.86 $2.28 Million - $2.71 Million	30,889 Added 3.65%	876,956 $73.7 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $2.41 Million - $3.16 Million	30,868 Added 3.79%	846,067 $76.3 Million
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $24.1 Million - $30.2 Million	-261,334 Reduced 24.28%	815,199 $77.7 Million
Q1 2021 May 12, 2021	BUY	$106.9 - $167.73 $10.6 Million - $16.7 Million	99,514 Added 10.19%	1,076,533 $123 Million
Q4 2020 Feb 12, 2021	BUY	$84.4 - $177.39 $9.98 Million - $21 Million	118,222 Added 13.77%	977,019 $135 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $72,615 - $89,550	995 Added 0.12%	858,797 $70.6 Million
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $1.92 Million - $3.19 Million	40,827 Added 5.0%	857,802 $67.1 Million
Q1 2020 May 14, 2020	BUY	$33.8 - $62.9 $2.44 Million - $4.54 Million	72,120 Added 9.68%	816,975 $36.3 Million
Q4 2019 Feb 13, 2020	BUY	$36.08 - $45.83 $475,390 - $603,856	13,176 Added 1.8%	744,855 $31.8 Million
Q3 2019 Nov 12, 2019	BUY	$42.5 - $63.11 $314,075 - $466,382	7,390 Added 1.02%	731,679 $31.3 Million
Q2 2019 Aug 14, 2019	BUY	$54.93 - $74.36 $2.91 Million - $3.94 Million	53,043 Added 7.9%	724,289 $46 Million
Q1 2019 May 14, 2019	BUY	$39.87 - $69.36 $4.11 Million - $7.15 Million	103,016 Added 18.13%	671,246 $46.6 Million
Q4 2018 Feb 13, 2019	BUY	$38.89 - $77.3 $2.45 Million - $4.88 Million	63,118 Added 12.5%	568,230 $24.7 Million
Q3 2018 Nov 13, 2018	BUY	$71.81 - $90.15 $1.84 Million - $2.31 Million	25,598 Added 5.34%	505,112 $38.6 Million
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $2.16 Million - $3.79 Million	44,442 Added 10.21%	479,514 $36.9 Million
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $3.19 Million - $4.21 Million	71,882 Added 19.79%	435,072 $22.2 Million
Q4 2017 Feb 13, 2018	SELL	$43.54 - $57.32 $18,243 - $24,017	-419 Reduced 0.12%	363,190 $16.8 Million
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $765,272 - $1.02 Million	15,370 Added 4.41%	363,609 $19.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	348,239	348,239 $21.6 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History